000 | 03902nam a22005777a 4500 | ||
---|---|---|---|
008 | 170428s20172017 xxu||||| |||| 00| 0 eng d | ||
022 | _a2047-2404 | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a28200140 | ||
245 | _aSerial volumetric assessment of coronary fibroatheroma by optical frequency domain imaging: insights from the TROFI trial. | ||
251 | _aEuropean heart journal cardiovascular Imaging. 19(1):92-100, 2018 01 01. | ||
252 | _aEur Heart J Cardiovasc Imaging. 19(1):92-100, 2018 01 01. | ||
253 | _aEuropean heart journal cardiovascular Imaging | ||
260 | _c2017 | ||
260 | _fFY2017 | ||
265 | _sppublish | ||
266 | _d2017-05-06 | ||
520 | _aAims: Coronary lesions precursors of acute events remain elusive, since they undergo continuous changes and their temporal changes are not very well-characterized. In natural history studies, optical frequency domain imaging (OFDI) has been used only to assess fibroatheromas as a 2D structure and sometimes in a single frame fashion. We aim at describing the serial volumetric modifications of the fibrous cap (FC) of the fibroatheromas as determined by OFDI over a 6-month follow-up period. | ||
520 | _aConclusions: Non-culprit fibroatheromas located in the infarct related artery of patients with STEMI had a volumetric reduction of the FC after 6-month follow-up. Quantitative FC assessment was able to differentiate high-risk lesions that became ThCFAs. There was a considerable change of plaque phenotype (TCFAs or ThCFAs) over time. | ||
520 | _aCopyright Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: [email protected]. | ||
520 | _aMethods and results: In 49 patients, OFDI investigation was performed following treatment of culprit lesion and at 6-month follow-up in patients with ST-segment elevation myocardial infarction (STEMI). A fully automatic volumetric quantification of FC was done in all lipid-containing frames of non-culprit lesions in the infarct related artery. These lesions were matched at baseline and 6-month follow-up. A total of 58 non-culprit lipid rich lesions (34 TCFAs and 24 thick-cap fibroatheroma [ThCFA]) were found in 34 patients at baseline. Overall, there was a FC volume decrease of 1.57 (Inter-quartile Range [IQR] -4.13 to 0.54) mm3 at 6-months. 27% of the lesions changed their phenotype over time (TCFA or ThCFA). TCFAs that became ThCFAs at follow-up had smaller mean and maximal FC as compared with lesions that remained TCFAs (P = 0.01 for both). | ||
546 | _aEnglish | ||
650 | _a*Coronary Artery Disease/dg [Diagnostic Imaging] | ||
650 | _a*Plaque, Atherosclerotic/dg [Diagnostic Imaging] | ||
650 | _a*ST Elevation Myocardial Infarction/th [Therapy] | ||
650 | _a*Thrombectomy/mt [Methods] | ||
650 | _a*Tomography, Optical Coherence/mt [Methods] | ||
650 | _aAged | ||
650 | _aCombined Modality Therapy | ||
650 | _aCoronary Artery Disease/th [Therapy] | ||
650 | _aFemale | ||
650 | _aFollow-Up Studies | ||
650 | _aHumans | ||
650 | _aMale | ||
650 | _aMiddle Aged | ||
650 | _aPercutaneous Coronary Intervention | ||
650 | _aPlaque, Atherosclerotic/su [Surgery] | ||
650 | _aProspective Studies | ||
650 | _aRisk Assessment | ||
650 | _aST Elevation Myocardial Infarction/dg [Diagnostic Imaging] | ||
650 | _aST Elevation Myocardial Infarction/mo [Mortality] | ||
650 | _aSurvival Rate | ||
650 | _aTime Factors | ||
650 | _aTreatment Outcome | ||
651 | _aMedStar Heart & Vascular Institute | ||
657 | _aJournal Article | ||
700 | _aGarcia-Garcia, Hector M | ||
790 | _aCampos CM, Dijkstra J, Garcia-Garcia HM, Iqbal J, Muramatsu T, Nakatani S, Onuma Y, Serruys PW | ||
856 |
_uhttps://dx.doi.org/10.1093/ehjci/jew338 _zhttps://dx.doi.org/10.1093/ehjci/jew338 |
||
942 |
_cART _dArticle |
||
999 |
_c2139 _d2139 |